Figure 2From: Early perfusion changes in patients with recurrent high-grade brain tumor treated with Bevacizumab: preliminary results by a quantitative evaluationNormalized cerebral blood volume for each patient. Mean values of the normalized cerebral blood volume (nCBV), before treatment and after the first dose of bevacizumab, for each patient.Back to article page